On this page
KY
kyphoscoliosis peptidase
KY is located on the long (q) arm of chromosome 3, at band 3q22.2. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 3 in the library →Available at Jeen Health
Clinical tests that include this
Overview
The KY gene encodes kyphoscoliosis peptidase, a protein whose name derives from early associations with skeletal deformity phenotypes. Located on chromosome 3, this gene has been studied primarily in the context of muscle tissue, where the encoded protein appears to contribute to structural integrity or regulatory processes. While KY is not currently included in routine clinical genetic panels in the UK, research continues to clarify its biological role and the clinical significance of variants within this gene. Understanding KY contributes to the broader knowledge of muscle biology and potential inherited conditions affecting musculoskeletal health.
What the gene does
The kyphoscoliosis peptidase protein is thought to participate in muscle cell function, though mechanistic details remain under investigation. Current evidence suggests the protein may interact with components of the muscle cytoskeleton or contribute to signalling pathways that maintain muscle fibre integrity. Some studies indicate a potential role in skeletal muscle development or adaptation to mechanical stress, though the specific biochemical activities mediated by this protein have not been fully characterised. The protein's expression pattern in muscle tissue supports a tissue-specific function, distinguishing it from ubiquitously expressed structural proteins. Further research is needed to define the precise molecular partners and cellular processes regulated by kyphoscoliosis peptidase.
Video: Genetics 101
Chromosome location
KY is located on the long arm of chromosome 3 at position 3q22.2. This chromosomal region contains multiple genes involved in diverse cellular processes. The genomic structure of KY, including exon count and transcript variants, has been documented in genomic databases, though detailed annotation of regulatory elements remains ongoing. The chromosomal band 3q22.2 is a moderately gene-dense region, and positional mapping has helped researchers investigate potential functional neighbours and regulatory landscapes.
Protein structure
Domain architecture has not been experimentally characterised in detail for this protein. The length of the kyphoscoliosis peptidase protein has not been definitively established in all isoforms, reflecting gaps in structural annotation. Without detailed domain mapping, predictions about functional modules or interaction surfaces remain speculative. Structural biology techniques such as crystallography or cryo-electron microscopy have not yet resolved the three-dimensional architecture of this protein, limiting mechanistic insights.
Key variants
Genetic variants in KY include missense changes, insertions, deletions, and alterations affecting regulatory regions. The clinical interpretation of these variants is complicated by limited functional studies and variable inheritance patterns reported in the literature. Pathogenicity assessment relies on computational predictions, population frequency data, and segregation analysis in families when available. As research progresses, reclassification of variants may occur as new evidence emerges.
No pathogenic or likely-pathogenic ClinVar variants recorded yet for this gene.
Associated conditions
KY has been investigated in relation to muscle phenotypes, though no specific inherited conditions are definitively established as KY-related in major clinical databases at present. The inheritance pattern associated with KY variants appears to vary, with both dominant and recessive mechanisms proposed in different research contexts. Ongoing clinical and molecular studies aim to clarify genotype-phenotype correlations and establish clearer diagnostic criteria for KY-related conditions.
No disease links recorded for this gene in our reference set.
UK clinical status
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What does the KY gene do?
The KY gene encodes kyphoscoliosis peptidase, a protein thought to function in skeletal muscle tissue. Research suggests it may contribute to muscle structure or signalling, though its precise molecular role is still being investigated.
Are variants in KY clinically tested in the UK?
KY is not currently included in NHS Genomic Medicine Service clinical panels. Genetic testing for KY variants may be available through research studies or specialist referral, depending on clinical presentation.
What inheritance pattern is associated with KY?
The inheritance pattern for KY-related conditions appears to vary, with evidence suggesting both autosomal dominant and recessive mechanisms in different families. Clinical geneticists assess each case individually based on family history and variant characteristics.